A Case of Valproic-Acid Induced Hyperammonemic Encephalopathy
Open Access
- 13 December 2021
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 13 (12) , e20380
Abstract
Valproic acid (VPA), an antiepileptic medication, is known to cause hyperammonemia, which may be asymptomatic or can present with encephalopathy. VPA-induced hyperammonemic encephalopathy (VHE) is a serious but reversible condition, which requires high clinical suspicion for diagnosis. It may occur acutely or after chronic use of VPA. We present the case of a 44-year-old male who was on long-term VPA therapy for a seizure disorder. He presented to the emergency department with the complaint of two episodes of seizures two days before admission. On arrival, the patient was confused and tearful and was unable to recollect the events leading to the seizure. The initial complete metabolic panel, liver function tests, urinalysis, and serum VPA levels were observed to be normal. However, there was a marked elevation in ammonia levels. VPA was suspected to be the inciting agent of hyperammonemic encephalopathy, and, therefore, it was discontinued. The patient was started on oral lactulose and prescribed a different anti-seizure medication (i.e., lamotrigine). His ammonia levels decreased gradually, and his condition improved. Thus, it was concluded that the patient had developed VHE. At the time of discharge, he was stable and had no confusion or seizures. This case report evaluates his presentation and discusses the possible pathogenesis of VHE.Keywords
This publication has 14 references indexed in Scilit:
- Risk factors for valproic acid induced hyperammonemia and its association with cognitive functionsGeneral Hospital Psychiatry, 2019
- Valproic acid–induced hyperammonemia: Incidence, clinical significance, and treatment managementMental Health Clinician, 2018
- Topiramate-Related HyperammonemiaJournal of Pharmacy Technology, 2015
- Risperidone, a risk factor for valproate-induced encephalopathy?General Hospital Psychiatry, 2013
- Valproic acid-induced hyperammonemic encephalopathy – a potentially fatal adverse drug reactionSpringerPlus, 2013
- Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and managementGeneral Hospital Psychiatry, 2012
- A Case of Hyperammonemic Encephalopathy After 11 Years of Valproate TherapyJournal of Clinical Psychopharmacology, 2008
- Valproic acid-associated hyperammonemic encephalopathy: a case report from the psychiatric settingInternational Clinical Psychopharmacology, 2005
- Ammonia Induced Encephalopathy from Valproic Acid in a Bipolar Patient: Case ReportThe International Journal of Psychiatry in Medicine, 2003
- Simultaneous side effects of both clozapine and valproateIntensive Care Medicine, 2001